Novavax
NVAX
#4816
Rank
HK$16.50 B
Marketcap
HK$100.05
Share price
15.80%
Change (1 day)
54.34%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of June 2026 : HK$2.33 Billion

According to Novavax's latest financial reports the company's total debt is HK$2.33 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$1.93 B8.22%
2024-12-31HK$1.78 B-0.02%
2023-12-31HK$1.78 B-58.35%
2022-12-31HK$4.29 B21.34%
2021-12-31HK$3.54 B-2.42%
2020-12-31HK$3.62 B44.72%
2019-12-31HK$2.50 B0.29%
2018-12-31HK$2.49 B0.68%
2017-12-31HK$2.48 B1.21%
2016-12-31HK$2.45 B80025.5%
2015-12-31HK$3.06 M-60.45%
2014-12-31HK$7.74 M-46.93%
2013-12-31HK$14.58 M56.16%
2012-12-31HK$9.34 M275.8%
2011-12-31HK$2.48 M-20.16%
2010-12-31HK$3.11 M-17.39%
2009-12-31HK$3.76 M-97.87%
2008-12-31HK$0.17 B-0.2%
2007-12-31HK$0.17 B-1.65%
2006-12-31HK$0.18 B-23.81%
2005-12-31HK$0.23 B-18.04%
2004-12-31HK$0.28 B-11.63%
2003-12-31HK$0.32 B1.22%
2002-12-31HK$0.32 B20.6%
2001-12-31HK$0.26 B71.65%
2000-12-31HK$0.15 B19978.55%
1999-12-31HK$0.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
HK$384.62 B 16,385.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$495.89 B 21,154.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$252.98 B 10,743.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$189.63 B 8,028.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$8.20 B 251.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$38.48 M-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.31 B-86.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$11.77 M-99.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$6.22 B 166.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$4.56 B 95.68%๐Ÿ‡บ๐Ÿ‡ธ USA